2E-3-F16
2E-3-F16 is a anticancer agent. 2E-3-F16 exhibits tumor cell selectivity between NCI-H446 cancer cells and HBE cells. 2E-3-F16 enhances the sensitivity of A549 cells to Cisplatin.
Product Specifications
CAS Number
3002962-69-5
UNSPSC
12352005
Target
Apoptosis; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/2e-3-f16.html
Solubility
10 mM in DMSO
Smiles
C=CCC1=CC(C2=CC=C(C(CC=C)=C2)OCCC[N+]3=CC=C(C=C3)/C=C/C4=CNC5=C4C=CC=C5)=C(C=C1)OCCC.[Br-]
Molecular Formula
C39H41BrN2O2
Molecular Weight
649.66
References & Citations
[1]Miao H, et al. Mitochondrial targeting derivatives of honokiol enhanced selective antitumor activity in NCI-H446 cells and decreased in vivo toxicity in Caenorhabditis elegans. Eur J Med Chem. 2023 Dec 3;264:115996.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041857-500 1x 500 µL
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![FITC Anti-Mouse Ly6G Antibody[1A8]](https://cdn.genprice.uk/products/763/68dd14ac061270361e7d305a/imageurl/e-ab-f1108c.webp)